Angiotensin II is a key regulator of blood pressure and cardiovascular function in mammals. The conversion of angiotensin into its active form is carried out by Angiotensin I-Converting Enzyme (ACE). The measurement of ACE concentration in plasma or serum, its enzymatic activity, and the correlation between an insertion/deletion (I/D) genetic polymorphism of the ACE gene have been investigated as possible indicators of superior athletic performance in humans. In this context, other indicators of superior adaptation to exercise resulting in better athletic performance (such as ventricular hypertrophy, VO 2 max, and competition results) were mostly used to study the association between ACE I/D polymorphism and improved performance. Despite the fact that the existing literature presents little consensus, there is sufficient scientific evidence to warrant further investigation on the usage of ACE activity and the I/D ACE gene polymorphism as biomarkers of superior athletic performance in humans of specific ethnicities or in athletes involved in certain sports. In this sense, a biomarker would be a substance or genetic component that could be measured to provide a degree of certainty, or an indication, of the presence of a certain trait or characteristic that would be beneficial to the athlete’s performance. Difficulties in interpreting and comparing the results of scientific research on the topic arise from dissimilar protocols and variation in study design. This review aims to investigate the current literature on the use of ACE I/D polymorphism as a biomarker of performance in humans through the comparison of scientific publications.
References
[1]
Rigat, B.; Hubert, C.; Alhenc-Gelas, F.; Cambien, F.; Corvol, P.; Soubrier, F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J. Clin. Invest.？1990, 86, 1343–1346, doi:10.1172/JCI114844.
[2]
De Mello Costa, M.F. Angiotensin-Converting Enyzme (ACE) in Horses and Its Relationship to Performance and Fitness. Ph.D. Thesis, The University of Melbourne, Melbourne, Victoria, Australia, 2010.
[3]
Montgomery, H.; Marshall, R.; Myerson, S.; Clarkson, P.; Dollery, C.; Haynard, M.; Holliman, D.E.; Jubb, M.; World, M.; Thomas, E.L.; Brynes, A.E.; Saeed, N.; Barnard, M.; Dell, J.D.; Prasad, K.; Rayson, M.; Talmud, P.J.; Humphries, S.E. Human gene for physical performance. Nature？1998, 393, 221–222, doi:10.1038/30374.
[4]
Montgomery, H.E.; Clarkson, P.; Dollery, C.M.; Prasad, K.; Losi, M.A.; Hemingway, H.; Statters, D.; Jubb, M.; Girvain, M.; Varnava, A.; World, M.; Deanfield, J.; Talmud, P.; McEwan, J.R.; McKenna, W.J.; Humphries, S. Association of angiotensin-converting enzyma gene I/D polynorphism with change in left ventricular mass in response to physical training. Circulation？1997, 96, 741–747, doi:10.1161/01.CIR.96.3.741.
[5]
Montgomery, H.; Clarkson, P.; Barnard, M.; Bell, J.; Brynes, A.; Dollery, C.; Hajnal, J.; Hemingway, H.; Mercer, D.; Jarman, P.; Marshall, R.; Prasad, K.; Rayson, M.; Saeed, N.; Talmud, P.; Thomas, L.; Jubb, M.; World, M.; Humphries, S. Angiotensin-converting enzyme gene insertion/deletion polymorphism and response to physical training. Lancet？1999, 353, 541–545, doi:10.1016/S0140-6736(98)07131-1. 10028982
[6]
Myerson, S.; Hamingway, H.; Budget, R.; Martin, J.; Humphries, S.; Montgomery, H. Human angiotensin I-converting enzyme gene and endurance performance. J. Appl. Physiol.？1999, 87, 1313–1316. 10517757
[7]
Bowen, I.M.; Marr, C.M.; Elliot, J. Drugs acting on the cardiovascular system. In Equine Clinical Pharmacology, 1st ed.; Bertone, J.J., Horspool, L.J.I., Eds.; Elsevier: London, UK, 2004; pp. 193–215.
[8]
McKeever, K.H.; Gordon, M.E. Endocrine alterations in the equine athlete. In Equine Exercise Physiology; Hinchcliff, K.W., Geor, R.J., Kaneps, A.J., Eds.; Saunders Elsevier: Philadelphia, PA, USA, 2008; pp. 274–300.
[9]
Robertson, J.I.S.; Nicholls, M.G. The Renin-Angiotensin System; Gower Medical Publishing: London, UK, 1993; Volume 1, p. 511.
[10]
McKeever, K.H.; Gordon, M.B. Endocrine alterations in the equine athlete. In Equine Sports Medicine and Surgery, 1st ed.; Hinchcliff, K.W., Kaneps, A.J., Geor, R.J., Eds.; W.B. Saunders: Philadelphia, PA, USA, 2004; pp. 793–814.
[11]
Rigat, B.; Hubert, C.; Corvol, P.; Soubrier, F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase1). Nucl. Acid Res.？1992, 20, 1433.
[12]
Hubert, C.; Houot, A.M.; Corvol, P.; Soubrier, F. Structure of the angiotensin I-converting enzyme gene. J. Biol. Chem.？1991, 23, 15377–15383.
Nagashima, J.; Musha, H.; Takada, H.; Awaya, T.; Oba, H.; Mori, N.; Ohmiya, K.; Nobuoka, S.; Murayama, M. Influence of angiotensin-converting enzyme gene polymorphism on development of athlete’s heart. Clin. Cardiol.？2000, 23, 621–624, doi:10.1002/clc.4960230814.
[15]
Collins, E.; Xenophontos, S.L.; Cariolou, M.A.; Mokone, G.G.; Hudson, D.E.; Anastasiades, L.; Noakes, T.D. The ACE gene and endurance performance during the South African Ironman triathlons. Med. Sci. Sport Exercise？2004, 36, 1314–1320, doi:10.1249/01.MSS.0000135779.41475.42.
[16]
Cam, F.S.; Colakoglu, M.; Sekuri, C.; Colakoglu, S.; Sahan, ？.; Berdeli, A. Association between the ACE I/D gene polymorphism and physical performance in a homogenous non-elite cohort. Can. J. Appl. Physiol.？2005, 30, 74–86, doi:10.1139/h05-106.
[17]
Scott, R.A.; Moran, C.; Wilson, R.H.; Onywera, V.; Boit, M.K.; Goodwin, W.H.; Gohlke, P.; Payne, J.; Montgomery, H.; Pitsiladis, Y.P. No association between angiotensin converting enzyme (ACE) gene variation and endurance athlete status in Kenyans. Comp. Biochem. Physiol.？2005, 141, 169–175, doi:10.1016/j.cbpb.2005.05.001.
[18]
Karjalainen, J.; Kujala, U.M.; Stolt, A.; M？ntysaari, M.; Viitasalo, M.; Kainulainin, K.; Kontula, K. Angiotensin Gene M235T polymorphism predicts left ventricular hypertrophy in endurance athletes. J. Amer. Coll. Cardiol.？1999, 34, 494–499, doi:10.1016/S0735-1097(99)00199-0.
[19]
Rankinen, T.; Wolfarth, B.; Simoneau, J.A.; Maier-Lenz, D.; Rauramaa, R.; Rivera, M.A.; Boulay, M.R.; Chagnon, Y.C.; Perusse, L.; Keul, J.; Bouchard, C. No association bewteen the angiotensin-converting enzyme ID polymorphism and elite endurance athlete status. J. Appl. Physiol.？2000, 88, 1571–1575. 10797114
[20]
Rankinen, T.; Perusse, L.; Rauramaa, R.; Rivera, M.A.; Wolfarth, B.; Bouchard, C. The human gene map for performance and health-related fitness phenotypes. Med. Sci. Sport Exercise？2001, 33, 855–867, doi:10.1097/00005768-200106000-00001.
[21]
Perusse, L.; Rankinen, T.; Rauramaa, R.; Rivera, M.A.; Wolfarth, B.; Bouchard, C. The human gene map for performance and health-related fitness phenotypes: The 2002 update. Med. Sci. Sport Exercise？2003, 35, 1248–1264, doi:10.1249/01.MSS.0000078938.84161.22.
[22]
Bray, M.S.; Hagberg, J.M.; Perusse, L.; Rankinen, T.; Roth, S.M.; Wolfarth, B.; Bouchard, C. The human gene map for performance and health-related fitness phenotypes: The 2006-2007 update. Med. Sci. Sport Exercise？2009, 41, 35–73.
[23]
Bae, J.S.; Kang, B.Y.; Lee, K.O.; Lee, S.T. Genetic variation in the renin-angiotensin system and response to endurance training. Med. Princip. Pract.？2007, 16, 142–146, doi:10.1159/000098368.
[24]
álvarez, R.; Terrados, N.; Ortolano, R.; Iglesias-Cubero, G.; Reguero, J.R.; Batalla, A.; Cortina, A.; Fernádez-García, B.; Rodríguez, C.; Braga, S.; Alvarez, V.; Coto, E. Genetic variation in the renin-angiotensin system and athletic performance. Eur. J. Appl. Physiol.？2000, 82, 117–120, doi:10.1007/s004210050660.
[25]
Gayagay, G.; Yu, B.; Hambly, B.; Boston, T.; Hahn, A.; Celermajer, D.S.; Trent, R.J. Elite endurance athletes and the ACE I allele- the role of genes in athletic performance. Hum. Genet.？1998, 103, 48–50, doi:10.1007/s004390050781.
[26]
Woods, D.; Hickman, M.; Jamshidi, Y.; Brull, D.; Vassiliou, V.; Jones, A.; Humphries, S.; Montgomery, H. Elite swimmers and the D allele of the ACE I/D polymorphism. Hum. Genet.？2001, 108, 230–232, doi:10.1007/s004390100466.
[27]
Amir, O.; Amir, R.; Yamin, C.; Attias, E.; Eynon, N.; Sagiv, M.; Sagiv, M.; Meckel, Y. The ACE deletion allele is associated with Israeli elite endurance athletes. Exp. Physiol.？2007, 92, 881–886, doi:10.1113/expphysiol.2007.038711.
